# Study of the Sars-Cov2 Neuroinvasiveness - COVID19

> **NCT04427254** · NA · TERMINATED · sponsor: **Fondation Ophtalmologique Adolphe de Rothschild** · enrollment: 2 (actual)

## Conditions studied

- COVID19

## Interventions

- **DRUG:** Cerebrospinal fluid sampling, meningeal and brain parenchyma biopsies

## Key facts

- **NCT ID:** NCT04427254
- **Lead sponsor:** Fondation Ophtalmologique Adolphe de Rothschild
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-06-26
- **Primary completion:** 2022-11-25
- **Final completion:** 2022-11-25
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** enrollment number not reached
- **Last updated:** 2023-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04427254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04427254, "Study of the Sars-Cov2 Neuroinvasiveness - COVID19". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04427254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*